A major clinical trial revealed that the weight loss drug Wegovy reduced the risk of heart attack, stroke, or heart-related death by 20% for people with cardiovascular disease.
Doctors said the findings, which have not yet been peer-reviewed or published in a medical journal, may encourage more people to use the popular weight-loss drug. According to CNN.
Novo Nordisk said Wegovy had a “safe and well-tolerated profile” in the study, which is consistent with what it has seen in previous trials.
The company indicated that it would file requests with regulators to add cardiovascular benefits to the drug’s prescribing information.
2023-08-09 18:55:29
#Discovery #popular #weightloss #drug #reduces #risk #heart #attacks #strokes
Related posts:
Preventing Cardiovascular Disease through Lifestyle Changes: The Link Between Oral Health and Heart ...
Private Hospitals Syndicate Reveals Promised Solution to Dialysis Crisis in Lebanon
Medicaid limits access to life-saving doses of addiction treatment - Kabargayo
Neanderthals' ears were cut out for human chatter (and possibly chatters themselves)
